Predict your next investment

Holding Company
FINANCIAL | Securities Brokers & Traders
pingansecgp.com

See what CB Insights has to offer

Stage

IPO

Portfolio Exits

1

Investments

1

Pingan Securities Funding, Pingan Securities Valuation & Pingan Securities Revenue

1 Fundings

Pingan Securities's latest funding round was a IPO for on January 3, 1980.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/3/1980

IPO

$0.00B

((9.99x))

FY 1234

1

Date

1/3/1980

Round

IPO

Amount

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

Pingan Securities Investments

1 Investments

Pingan Securities has made 1 investments. Their latest investment was in Chinagreen Biological Technology as part of their Series C - III on December 12, 2016.

CBI Logo

Pingan Securities Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/22/2016

Series C - III

Chinagreen Biological Technology

$12.8M

Yes

1

Date

12/22/2016

Round

Series C - III

Company

Chinagreen Biological Technology

Amount

$12.8M

New?

Yes

Co-Investors

Sources

1

Pingan Securities Portfolio Exits

1 Portfolio Exit

Pingan Securities has 1 portfolio exit. Their latest portfolio exit was Chinagreen Biological Technology on April 12, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/12/2021

IPO

$991

2

Date

4/12/2021

Exit

IPO

Companies

Valuation

$991

Acquirer

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.